Skip to main content

Table 3 Cost per QALY from societal perspective

From: Should Israel screen all mothers-to-be to prevent early-onset of neonatal group B streptococcal disease? A cost-utility analysis

% getting

% of meningitis cases with long-term sequelae

Anaphalaxis From IAP

22.5%

35%

47.5%*

60%

0%

68,536

36,609

5,558

cs

0.001%

69,883

37,336

5,749

cs

0.004%

74,252

39,690

6,155

cs

0.022%*

117,993

63,025

10,641

cs

0.040%

279,253

145,536

25,857

cs

  1. * baseline rate.
  2. cs denotes cost-saving.